Lonza Benelux

Foundation date

1897

Sector

#Biotechnology / R&D Services

Subsector

Lonza is one of the world’s largest companies for contract development and manufacturing, recognized for reliable, high-quality services, regulatory track record, global footprint, innovative technology platforms and over 35 years of experience in mammalian cell culture.

Lonza customers need to maintain high productivity, product quality and reproducibility when moving from the research phase into clinical and commercial manufacturing, rapidly bringing candidates to the clinic and products to market. A successful outcome will often require significant technical expertise and advanced development and manufacturing technologies.

In Lonza’s extensive contract development and manufacturing services portfolio, Lonza uses advanced technologies to quickly and efficiently deliver products such as monoclonal antibodies, complex proteins and recombinant proteins. Their biologics offering spans from preclinical services, clinical drug product and drug substance and commercial supply in Mammalian, Microbial, ADCs / Bioconjugates, mRNA and Cell & Gene Therapies.

Lonza works in partnership with customers of all sizes, from start-ups to large biotechs and pharmaceutical companies, and can tailor our products and services to your specific needs, budget and timelines

Upcoming events

Latest news

  • New way of twisting fibers improves energy storage in wearable devices

    Friday November 22nd 2024

  • Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation

    Thursday November 21st 2024

  • argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

    Wednesday November 20th 2024